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Summary
 
T lymphocytes express two Src tyrosine kinases, Lck and Fyn. While thymocyte and T cell
subsets are largely normal in 
 
fyn
 
2
 
/
 
2
 
 mice, animals lacking Lck have impaired T cell develop-
ment. Here, it is shown that Fyn is required for the rapid burst of interleukin (IL)-4 and IL-13
synthesis, which occurs promptly after T cell receptor activation. The lack of cytokine induction
in 
 
fyn
 
 mutant mice is due to a block in natural killer (NK) T cell development. Studies using
bone marrow chimeras indicate that the defect behaves in a cell-autonomous manner, and the lack
of NK T cells is probably not caused by inappropriate microenvironmental cues. Both NK T
cells and conventional T cells express similar levels of Lck, implying that Fyn and Lck have distinct
roles in regulating NK T cell ontogeny. The 
 
fyn
 
 mutation defines the first signaling molecule
that is selectively required for NK T cell, but not for T lymphocyte or NK cell development.
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T
 
he Src family of tyrosine kinases plays an important role
in the transduction of signals necessary for the devel-
opment or activation of various cell types (for a review, see
reference 1). T lymphocytes and NK cells express mainly
two Src kinase family members, Fyn and Lck. By analyzing
mouse mutants, Fyn has been found to have a role in regu-
lating calcium flux and proliferation induced by ligation of
the TCR or Thy-1, especially in single positive thymocytes
(2, 3). These defects do not appear to compromise T cell de-
velopment, as normal numbers of T cell subsets are present
in the thymus and periphery of 
 
fyn
 
-deficient animals, and T
cell function is largely normal. In contrast, mice deficient in
 
lck
 
 have a block in T cell development, resulting in reduced
numbers of immature CD4
 
1
 
CD8
 
1
 
 
 
double positive as well
as mature single positive (CD4
 
1
 
 or CD8
 
1
 
) T lymphocytes
(4). Although each kinase appears to have distinct functions
during T cell ontogeny, Fyn also can partially compensate
for loss of Lck, since mice deficient in both 
 
fyn
 
 and 
 
lck
 
 have
a profound block in T cell development at the double nega-
tive stage, similar to recombination activating gene–deficient
(RAG
 
2
 
/
 
2
 
) mice (5, 6). Interestingly, mice deficient in either
 
fyn
 
 or 
 
lck
 
 alone exhibit normal numbers of 
 
g
 
/
 
d
 
 intraepithe-
lial lymphocytes (IELs), whereas 
 
fyn/lck
 
 double mutants have
few 
 
g
 
/
 
d
 
 IELs (7). This suggests that Fyn and Lck have re-
dundant functions during 
 
g
 
/
 
d
 
 IEL development, but only
partially overlapping roles in 
 
a
 
/
 
b
 
 T cell development.
Moreover, the double mutant mice also have normal NK
cell development and function (5). These observations raise
the question of whether development of NK T cells, a
unique lymphoid population that has characteristics of
both NK cells and T lymphocytes, will be dependent on
Src kinases as well.
NK T cells comprise 
 
z
 
0.5% of the thymus and 1% of the
spleen (for a review, see reference 8). The majority of NK T
cells express a TCR with a restricted V
 
a
 
 chain (V
 
a
 
14J
 
a
 
281)
and have biased V
 
b
 
 usage, 
 
.
 
50% V
 
b
 
8 (9–11). The expres-
sion of typical NK markers such as NKR-P1C, members of
the Ly49 family, and IL-2R
 
b
 
 demonstrates their affiliation
to the NK lineage. These cells are known to secrete large
amounts of cytokines, especially IL-4 and IFN-
 
g
 
 after TCR
cross-linking (12, 13). In fact, in the first hours after in vivo
activation of the TCR, NK T cells are the major source of
IL-4 (14). There is also evidence to suggest that NK T cells
may play a role in a variety of other immune functions, in-
cluding tumor surveillance, autoimmunity, and responses to
glucosyl phosphatidylinositol (GPI)-linked antigens (8, 15).
Although the ontogeny of NK T cells remains poorly
understood, they do have some unique developmental re-
quirements. Unlike conventional T cells, which use classical
MHC expressed by thymic epithelium for selection, mu-
rine NK T cells recognize the nonclassical MHC-like mol-
ecule, CD1d, expressed on bone marrow–derived cells (for
a review, see reference 8). Consequently, the targeted dis-
ruption of the CD1.1 gene abrogates NK T cell develop-
ment (16–18). The thymus is the major site of NK T cell
development, as demonstrated by the ability to develop
NK T cells in thymic organ culture and the drastic reduc-
tion in NK T cells in thymectomized mice (19, 20). De-
spite this, other studies indicate that at least a proportion of
NK T cells can develop extrathymically (21, 22). While 
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NK cells and T lymphocytes have distinct developmental
requirements, NK T cells have characteristics of both. For
example, T cells and NK T cells require CD3
 
z
 
 and pre–
TCR-
 
a
 
 (23, 24), but like NK cells, NK T cell develop-
ment is also dependent on IL-2R
 
b
 
 (25). Although the sig-
naling requirements for NK T cell development remain
poorly defined, some evidence suggests that it may differ
from conventional T cells. The Ras/Raf/Mek/MAP kinase
cascade is not necessary for NK T cell ontogeny, but is re-
quired for positive selection of conventional T cells (26).
Therefore, at least some receptor-distal signaling pathways
are used differently between T and NK T cells.
In this study, we demonstrate the necessity of the Fyn ty-
rosine kinase in NK T cell development. 
 
fyn
 
 mutant mice
fail to produce the initial burst of IL-4 or IL-13 after CD3
cross-linking in vivo or in vitro. This is due to an absence of
NK T cells in the thymus and periphery as assessed by flow
cytometric analysis and reverse transcription (RT)-PCR for
the canonical V
 
a
 
14J
 
a
 
281 TCR. This appears to be a cell-
autonomous defect rather than microenvironmental effect,
since NK T cells do not arise when 
 
fyn
 
 mutant bone marrow
is injected into irradiated wild-type hosts. Finally, NK T cells
express both Lck and Fyn, suggesting a specific role for Fyn
in NK T cell ontogeny that cannot be compensated for by
Lck. This is the only mutation reported to date involved
with signal transduction that specifically abolishes NK T cell
development, leaving all other lymphoid lineages intact.
 
Materials and Methods
 
Mice.
 
The 
 
fyn
 
 mutation (2) is maintained on a mixed (129 
 
3
 
B6) genetic background, but mice were homozygous for the
NKR-P1C allele recognized by the NK1.1 antibody. In some
experiments, 
 
fyn
 
 mutants that had been backcrossed 10 genera-
tions to C57Bl/6 were also used. Mice on the C57Bl/6 back-
ground that were deficient for either 
 
b
 
2-microglobulin (
 
b
 
2M) or
Lck were purchased from The Jackson Laboratory. C57Bl/6 and
129Sv mice were bred on site. All mice used in these studies were
from 7 to 12 wk of age and were maintained under American As-
sociation of Accreditation of Laboratory Animal Care (AALAC)
and institutional approved guidelines.
 
Antibodies and Flow Cytometry.
 
Thymocyte and splenocyte
suspensions were filtered through mesh to obtain single cell cul-
tures. Spleen suspensions were also depleted of red blood cells by
treating with 0.14 M ammonium chloride. Liver lymphocytes
were obtained as detailed elsewhere (27). The following antibodies
were used for flow cytometric analysis: anti–TCR-
 
b
 
–FITC (H57-
597), anti-NK1.1–PE (PK 136), Fc block (2.4G4), anti-CD4–PE
(GK1.5), anti-Ly9.1–FITC (30C7), and anti–heat stable antigen
(HSA)–biotin (M1/69) from PharMingen, and Tricolor-strepavi-
din from Caltag. Three-color immunofluorescence analysis was
performed using a FACScan™ flow cytometer (Becton Dickin-
son) and analyzed using CELLQuest™ software.
 
Quantitative RT-PCR.
 
The V
 
a
 
14J
 
a
 
281 rearrangement was
detected after RT of 5 
 
m
 
g total RNA using random hexamers and
Superscript II reverse transcriptase (GIBCO BRL). Quantitative
PCR was performed using the LightCycler (Roche Molecular
Biochemicals). In brief, 2 
 
m
 
l of a 1:4 dilution of the RT reaction
was amplified in the following reaction mixture: 67 mM Tris, pH
8.8, 16.6 mM ammonium sulfate, 6.7 mM magnesium chloride,
5 mM 
 
b
 
-mercaptoethanol, 0.01% gelatin, 10% DMSO, 1 mM
dNTPs, 100 ng each primer, 1.5 U Taq, and a 1:20,000 dilution
of SYBR green gel stain (Roche Molecular Biochemicals). A
standard curve was made using dilutions of an RT reaction from
C57Bl/6 splenocytes. The relative value for each sample was then
calculated using the LightCycler software. To control for varia-
tions in the RT reaction, all PCR reactions were normalized for
hypoxanthine phosphoribosyltransferase (HPRT) expression. The
following primers were used: HPRT sense, GTAATGATCAG-
TCAACGGGGGAC; HPRT antisense, CCAGCAAGCTTGCA-
ACCTTAACCA; V
 
a
 
14 5
 
9
 
, CTAAGCACAGCACGCTGCACA;
J281 3
 
9
 
, CAGGTATGACAATCAGCTGAGTCC (9).
 
RNase Protection.
 
To induce cytokines in vivo, mice were in-
jected intravenously through the retroorbital sinus with either 5 
 
m
 
g
anti-CD3 (2C11) or PBS. After 1.5 h, the mice were killed, spleno-
cytes were isolated, and RNA was purified. For the in vitro studies,
T cells were enriched for by passing splenocytes over a nylon wool
column. The suspensions averaged 80–90% T cells. Aliquots of
20 
 
3
 
 10
 
6
 
 cells were stimulated in a 2-ml volume with 5 
 
m
 
g/ml
anti-CD3 (2C11) and 1 ng/ml PMA or 1 ng/ml PMA and 500
nM ionomycin at 37
 
8
 
C. After 2 h, RNA was isolated and 7.5 
 
m
 
g
of RNA was analyzed using the RiboQuant RNase protection
assay system (PharMingen), probe set m-CK1. The samples were
separated on a 5% acrylamide/urea gel and dried at 80
 
8
 
C for 60
min. The gels were then exposed on a PhosphorImager
 
®
 
 (Molecu-
lar Dynamics) or directly onto film.
 
Cell Sorting and Western Blot.
 
Thymocytes from five C57Bl/6
mice were cultured in 6-well dishes at 30 
 
3
 
 10
 
6
 
 cells/ml in DMEM
supplemented with 10% heat-inactivated fetal bovine serum, 25
IU/ml penicillin, 25 
 
m
 
g/ml streptomycin, 50 mM 
 
b
 
-mercaptoeth-
anol, 11 
 
m
 
g/ml sodium pyruvate, 3.6 
 
m
 
g/ml asparagine, 0.6 
 
m
 
g/ml
folic acid, 11.2 
 
m
 
g/ml arginine, and 150 U/ml human recombi-
nant (hr)IL-2 (Roche Molecular Biochemicals) plus 1% condi-
tioned media from the IL-7–producing cell line, J558. After 5 d,
dead cells were removed by centrifugation through Lympholyte-M
(Accurate Chemical, Inc.). The cells were then cultured at 2 
 
3
 
10
 
5
 
 cells/ml in media with 150 U/ml hrIL-2. After 3 d, the cells
were harvested and used for fluorescent sorting after staining with
anti-NK1.1–PE and anti–TCR-
 
b
 
–FITC. Protein lysates were
resolved by 8% SDS-PAGE, then transferred to polyvinylidene
difluoride membrane (NEN). The membrane was blocked using
TNB buffer (30 mM Tris, pH 7.6, 75 mM NaCl, and 3% bovine
serum albumin) overnight at 4
 
8
 
C. Polyclonal anti-Fyn (Santa
Cruz Biotechnology) or anti-Lck (Upstate Biotechnology) was
added at concentrations suggested by the manufacturers and incu-
bated for 1 h. The membrane was then incubated with 0.5 
 
m
 
Ci/ml
iodinated protein A for 1 h at room temperature, and washed
with TBST (30 mM Tris, pH 7.6, 75 mM NaCl, and 0.2%
Tween 20) for 1 h followed by autoradiography.
 
Radiation Chimeras.
 
6-wk-old 129Sv mice received 700 rads
whole body irradiation from a cesium source. 5 
 
3
 
 10
 
6
 
 C57Bl/6
strain bone marrow cells (Fyn, 
 
b
 
2M, or wild-type), plus 1 
 
3
 
 10
 
6
 
129Sv bone marrow cells were then injected intravenously
through the retroorbital sinus. Thymus and spleen were harvested
after 10–12 wk and analyzed by flow cytometry for the presence
of NK T cells. The relative contribution of C57Bl/6 and 129Sv
cells to the hematopoietic lineages was assessed by monitoring
Ly9.1 expression, which is present only on 129Sv-derived cells.
 
Results
 
Impaired IL-4 Synthesis in fyn Mutants.
 
Since 
 
fyn
 
 mutant
mice synthesize reduced amounts of IL-2 after cross-link- 
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ing of the TCR (2), we measured the induction of T cell–
produced cytokines, IL-4 and IL-13, after TCR engagement
to determine whether their production was also impaired.
Splenic T cells from naive wild-type and 
 
fyn
 
 mutants were
isolated and stimulated in vitro with anti-CD3
 
e
 
 plus PMA
for 2 h. No IL-4 RNA was detected in the 
 
fyn
 
 mutant cul-
tures (Fig. 1 A), but was present in the wild-type cells. Ad-
ditionally, induction of IL-13, which shares some common
regulatory elements and functions with IL-4 (for a review,
see reference 28), also does not occur in the mutant cells.
Longer incubation with antibody still failed to elicit IL-4 or
IL-13 in the mutant cultures (data not shown). To confirm
the in vitro data, naive mice were injected with anti-CD3
 
e
 
antibody to induce cytokine production. Analysis of spleens
from treated mice again revealed that no IL-4 or IL-13
RNA was induced in the 
 
fyn
 
 mutants, whereas they were
readily detectable in wild-type mice (Fig. 1 B). To deter-
mine if the failure in IL-4 production was due to defective
activation through the TCR, T cells were treated in vitro
with ionomycin and PMA to bypass the requirement for
surface receptors. Splenic T cells from wild-type mice pro-
duced abundant amounts of IL-4 and IL-13 RNA, but
again none was induced in 
 
fyn
 
-deficient T cells (Fig. 1 A).
One interpretation of these data is that Fyn may be re-
quired for proper development of the T cell subset(s) capa-
ble of rapid IL-4/IL-13 production.
 
fyn Mutants Have Highly Reduced Numbers of NK T Cells.
 
The rapid accumulation of IL-4 after TCR engagement has
been shown to originate mostly from the NK T cell subset
(14). The lack of IL-4 induction in 
 
fyn
 
 mutants suggests
that this cell type may be missing or nonfunctional. To ad-
dress this, lymphocytes were isolated from thymus, spleen,
or liver, and examined for the presence of NK T cells by
flow cytometric analysis (Fig. 2). Relative to wild-type ani-
mals, the number of NK T cells in 
 
fyn
 
2
 
/
 
2
 
 mice was re-
duced 10-fold in the thymus and 
 
.
 
5-fold in the spleen and
liver. This approached the limits of detection under the
conditions used. The NK T cell number was compared
with 
 
b
 
2M-deficient mice, since this mutation prevents NK
T cell development (19, 29). In all tissues examined, the 
 
fyn
 
mutant had roughly twice as many NK T cells as 
 
b2M
mice. These data indicate that loss of Fyn significantly dis-
rupts NK T cell development.
There Is a Cell-intrinsic Component to the Requirement of
Fyn in NK T Cell Development. Since NK T cells are se-
lected by CD1d, it was determined that fyn mutant mice
still express normal levels of CD1d in the thymus (data not
shown). This indicates that the fyn mutation does not dis-
rupt NK T cell development by affecting CD1d surface ex-
Figure 1. Rapid induction of IL-4 or IL-13 RNAs after CD3 cross-
linking fails to occur in fyn mutants. (A) Splenocytes from fyn mutant
(FYN) or wild-type (WT) mice were stimulated with 5 mg/ml anti-CD3
(2C11) and 1 ng/ml PMA or 1 ng/ml PMA and 500 nM ionomycin for 2 h
in vitro. RNA was harvested, and an RNase protection assay specific for
IL-4 and IL-13 was performed. L32 RNA expression was also determined
as a loading control (2STIM). (B) Wild-type and fyn2/2 mice were in-
jected intravenously with PBS or 5 mg of anti-CD3 antibody. The spleen
was harvested 1.5 h later, and IL-4/IL-13 RNA induction was measured
by RNase protection assay. Shown are representative data from three sep-
arate experiments.
Figure 2. Fyn and Lck are both required for
proper development of NK1.11TCR-b1 cells.
Thymocytes, splenocytes, and liver lymphocytes
were stained with HSA, TCR-b, and NK1.1.
After gating on HSAlow cells, two-color TCR-b
vs. NK1.1 plots were constructed. The percent-
age of cells positive for both NK1.1 and TCR
(NK T cells) in the circled gate is displayed in the
upper right quadrant of each plot. The data
shown are representative from 10 C57Bl/6 (B6,
Wt), 12 Fyn (129 3 B6 hybrid or B6), 4 Lck
(B6), and 5 b2M (B6) mice analyzed in 5 sepa-
rate experiments.1192 Fyn Regulates NK T Cell Development
pression. However, it remains a formal possibility that CD1d
or the stromal environment may be altered in the mutant
and prevent maturation of NK T cells. For example, CD1d
uses a tyrosine-based motif for entering the endocytic path-
way required for loading antigen and subsequent presentation
to NK T cells (30); perhaps phosphorylation by Fyn is re-
quired for targeting to endosomes. To determine whether
Fyn is required in accessory cells of the microenvironment
or directly in NK T cells, radiation chimeras were con-
structed. Since NK T cells are selected by bone marrow–
derived cells rather than thymic epithelia, it was necessary
to mix bone marrows from wild-type 129Sv mice with either
wild-type C57Bl/6 or mice on the C57Bl/6 background
that were mutant for fyn or b2M, then inject into irradiated
129Sv mice. Cells derived from the 129Sv bone marrow
should provide the appropriate environmental cues neces-
sary for C57Bl/6 wild-type or mutant cells to develop into
NK T cells. The 129Sv strain was selected for two reasons.
First, the 129Sv strain does not express the NK1.1 marker,
so any NK1.11TCR-a/b1 (NK T) cells detected must be
C57Bl/6 derived. Second, the 129Sv and C57Bl/6 strains
express different alleles of the Ly9 cell surface marker, and
the relative contributions of the two types of bone marrows
to the chimera can then be determined by flow cytometry.
Thymocytes from each group were analyzed for the
presence of NK T cells by flow cytometry. Irradiated mice
which received either wild-type or b2M mutant bone mar-
row developed NK T cells (Fig. 3 A). Since b2M is required
for stable surface expression of CD1, this result indicated
that the CD1d present on wild-type 129Sv cells was able to
complement the defect and allow the b2M-deficient lym-
phocytes to undergo selection and form NK T cells. In
contrast, mice receiving the mixture of 129Sv and fyn mu-
tant bone marrow had no detectable NK T cells. Because
the wild-type 129Sv–derived cells were unable to rescue
NK T cell development in the fyn mutant chimera, it is likely
that this is a cell-autonomous defect in the NK T cell or
progenitor. Fig. 3 B shows that all of the chimeras contain
C57Bl/6-derived thymocytes at similar levels. Chimerism
extended to the periphery, since spleens from all reconsti-
tuted mice contained C57Bl/6-derived NK cells and T lym-
phocytes as well (data not shown). This indicates that the
lack of NK T cells in the chimeras made from fyn mutants is
not due to poor colonization by fyn mutant bone marrow.
Both Fyn and Lck Are Required in NK T Cells. Lck appears
to be the predominant Src family member required for
conventional T cell development. However, from studies
using transgenic mice overexpressing Fyn, and mice with
mutations in both fyn and lck, it is clear that Fyn can par-
tially compensate for Lck and allow development of double
positive and mature single positive T cells, though at a
much reduced efficiency (5, 6). One possibility as to why
Fyn is required for NK T cell development is that Lck may
not be expressed during NK T cell development or in ma-
ture NK T cells, leaving Fyn as the only Src family member
required for a later expansion or survival of NK T cells. Al-
ternatively, Fyn may have a specific role that Lck cannot
compensate for. To distinguish between these two possibil-
ities, the expression of Lck and Fyn was determined in NK
T cells. Both conventional and NK T cells were purified
from thymocyte cultures, then examined for Lck and Fyn
expression by Western blot analysis. As shown in Fig. 4,
equivalent amounts of Lck and Fyn are present in both NK
T cells and conventional T cells. This suggests that Fyn and
Lck may have nonredundant roles in NK T cell ontogeny,
although it is still formally possible that Lck may not be ex-
pressed in some progenitor. This seems unlikely, since Lck
is expressed throughout normal T cell development as well
as in mature T cells and NK cells (31). These data demon-
strate that Lck is expressed in NK T cells as well.
To assess whether Lck is required for NK T cell devel-
opment, lck mutant mice were examined for the presence
Figure 3. The fyn mutation may function in a cell-autonomous man-
ner during NK T cell development. Irradiated mice were injected with a
mix of wild-type 129Sv (NK1.12; Ly9.11) and wild-type or mutant
C57Bl/6 (NK1.11; Ly9.12) derived bone marrow. (A) Reconstitution of
NK T cells in the thymus by the different bone marrows was assessed by
flow cytometry as in Fig. 2. NK T cells developed from wild-type (Wt)
and b2M mutant bone marrow, but not fyn mutant bone marrow. (B)
The relative contribution of 129Sv- and C57Bl/6-derived lymphoid cells
in the thymus was determined by comparing Ly9.1 expression on CD41
thymocytes by flow cytometry. All the radiation chimeras contain a mix
of CD41 thymocytes derived from the two strains. The data presented are
representative of two independent experiments (chimeras: wild-type, n 5
7; Fyn, n 5 7; b2M, n 5 4).1193 Gadue et al. Brief Definitive Report
of this population by flow cytometry (Fig. 2). The levels of
NK T cells were reduced 10–20-fold relative to wild-type
mice, and were equivalent to b2M mutant mice. Thus,
both Fyn and Lck are required during NK T cell develop-
ment. NK T cells are thought to progress through the pre-
TCR stage of T cell development due to their requirement
for pre–TCR-a (24). Since Lck is required for proper pre-
TCR signaling, it is expected that lack of Lck should have
an adverse effect on NK T cell development.
NK T cell ontogeny has been largely defined by various
mouse mutants. Mice lacking CD1 or b2M have an early
block in development as determined by a lack of cells using
the invariant Va14Ja281 TCR, as well as cells that express
NK cell markers in conjunction with the TCR. It has been
shown that the common cytokine receptor g chain is re-
quired for NK1.1 expression and IL-4 secretion, but not
for selection of Va14Ja281-positive cells (32). To gauge
where the block in development lies in fyn2/2 and lck2/2
mice, this rearrangement was assayed for by quantitative
RT-PCR using the LightCycler quantitative PCR machine
(Fig. 5). Low levels of this rearrangement were observed in
all of the mutant animals due to nonproductive or random
rearrangements as demonstrated by detectable Va14Ja281
rearrangements in NK T cell–deficient mice (e.g., b2M
mutants). The usage of this specific rearrangement is reduced
10- and 20-fold in fyn2/2 thymus and spleen, respectively.
In lck mutant mice, this rearrangement is decreased .20-
fold in both the thymus and spleen, similar to the levels ob-
served in b2M mice. These data, combined with the flow
cytometric analyses, suggest that the lck mutation leads to
an early block similar to that seen in b2M mice. However,
the amount of the invariant rearrangement present in fyn2/2
mice was about twofold higher than that found in either
the lck2/2 or b2M2/2 mice, confirming the flow cytometric
data. This suggests that lack of Fyn leads to drastic though
incomplete block in NK T cell development. Fyn may
have a role in an early selection event or later expansion
occurring after TCR rearrangement. Regardless, it is clear
that Fyn is required for more than just NK1.1 upregulation
and IL-4 secretion.
These studies demonstrate the requirement of the two
Src family members, Fyn and Lck, in NK T cell ontogeny.
Additionally, these results indicate that the rapid pulse of
IL-13 synthesis occurring after TCR ligation is most likely
due to NK T cells. While conventional T cell ontogeny is
highly dependent on Lck (4, 33, 34), the NK T cell subset
is the first lymphocyte population that also demonstrates a
strict requirement for Fyn during development. These ex-
periments underscore a novel role for Fyn in regulating
NK T cells, especially since this kinase is not required in
pre-TCR signaling, positive selection, and negative selec-
tion of conventional T cells (2, 3, 35). This suggests that NK
T cells use unique signals in their selection or expansion
process. The fyn mutation defines the first intracellular sig-
naling molecule that is selectively required for NK T cell,
but not for conventional T lymphocyte or NK cell devel-
opment. These and future studies will give insights into
where this unique lineage diverges from conventional T
cell development.
Figure 4. Both conventional T cells and NK T cells express similar levels of Lck and
Fyn. (A) Thymocytes were cultured from C57Bl/6 mice to enrich for NK T cells. The
cultures were sorted by FACS® into NK1.11TCR-b1 (NK T cell) and NK1.12TCR-b1
(T cell) populations. (B) These populations as well as brain extract from a fyn mutant
mouse as a negative control were then assayed for Fyn and Lck expression by Western
blot analysis.
Figure 5. Quantitative RT-PCR for the canonical Va14Ja281 rear-
rangement used by NK T cells. RNA was harvested from thymocytes and
splenocytes, then subjected to quantitative RT-PCR analysis. The data
presented have been normalized for HPRT expression (wild-type [Wt],
n 5 5; Fyn, n 5 5; b2M, n 5 4; Lck, n 5 4).1194 Fyn Regulates NK T Cell Development
We thank Dr. C. Guidos for supplying some of the Lck mutant mice for this study, and Dr. E. Heber-Katz
for critical reading of the manuscript.
This work was supported by grants from the National Institutes of Health, the Council for Tobacco Re-
search, and the Arthritis Foundation. P.L. Stein is a recipient of an Arthritis Foundation Investigator Award.
Address correspondence to Paul L. Stein, The Wistar Institute, 3601 Spruce St., Philadelphia, PA 19104.
Phone: 215-573-9271; Fax: 215-898-0663; E-mail: pstein@wistar.upenn.edu
Submitted: 3 August 1999  Accepted: 1 September 1999
References
1. Lowell, C.A., and P. Soriano. 1996. Knockouts of Src-family
kinases: stiff bones, wimpy T cells, and bad memories. Genes
Dev. 10:1845–1857.
2. Stein, P.L., H.M. Lee, S. Rich, and P. Soriano. 1992. pp59fyn
mutant mice display differential signaling in thymocytes and
peripheral T cells. Cell. 70:741–750.
3. Appleby, M.W., J.A. Gross, M.P. Cooke, S.D. Levin, X.
Qian, and R.M. Perlmutter. 1992. Defective T cell receptor
signalling in mice lacking the thymic isoform of p59fyn. Cell.
70:751–763.
4. Molina, T.J., K. Kishihara, D.P. Siderovski, W. van Ewijk,
A. Narendran, E. Timms, A. Wakeham, C.J. Paige, K.U.
Hartmann, A. Veillette, et al. 1992. Profound block in thy-
mocyte development in mice lacking p56lck. Nature. 357:
161–164.
5. van Oers, N.C., B. Lowin-Kropf, D. Finlay, K. Connolly,
and A. Weiss. 1996. ab T cell development is abolished in
mice lacking both Lck and Fyn protein tyrosine kinases. Im-
munity. 5:429–436.
6. Groves, T., P. Smiley, M.P. Cooke, K. Forbush, R.M. Perl-
mutter, and C.J. Guidos. 1996. Fyn can partially substitute
for Lck in T lymphocyte development. Immunity. 5:417–428.
7. Page, S.T., N.S. van Oers, R.M. Perlmutter, A. Weiss, and
A.M. Pullen. 1997. Differential contribution of Lck and Fyn
protein tyrosine kinases to intraepithelial lymphocyte devel-
opment. Eur. J. Immunol. 27:554–562.
8. Bendelac, A., M.G. Rivera, S. Park, and J. Roark. 1997.
Mouse CD1-specific NK1 T cells: development, specificity,
and function. Annu. Rev. Immunol. 15:535–562.
9. Lantz, O., and A. Bendelac. 1994. An invariant T cell recep-
tor a chain is used by a unique subset of major histocompati-
bility complex class I–specific CD41 and CD4282 T cells in
mice and humans. J. Exp. Med. 180:1097–1106.
10. Makino, Y., R. Kanno, T. Ito, K. Higashio, and M. Tanigu-
chi. 1995. Predominant expression of invariant Va141TCRa
chain in NK1.11 T cell populations. Int. Immunol. 7:1157–1160.
11. Ohteki, T., and R. MacDonald. 1996. Stringent Vb require-
ment for the development of NK1.11 T cell receptor-a/b1
cells in mouse liver. J. Exp. Med. 183:1277–1280.
12. Arase, H., N. Arase, K. Nakagawa, R. Goog, and K. Onoe.
1993. NK1.11 CD41 CD82 thymocytes with specific lym-
phokine secretion. Eur. J. Immunol. 23:307–310.
13. Hayakawa, K., B. Lin, and R.R. Hardy. 1992. Murine thy-
mic CD41 T cell subsets: a subset (Thy0) that secretes diverse
cytokines and overexpresses the Vb8 T cell receptor gene
family. J. Exp. Med. 176:269–274.
14. Yoshimoto, T., and W.E. Paul. 1994. CD41 NK1.11 T cells
promptly produce interleukin 4 in response to in vivo chal-
lenge with anti-CD3. J. Exp. Med. 179:1285–1295.
15. Schofield, L., M.J. McConville, D. Hansen, A.S. Campbell,
B. Fraser-Reid, M.J. Grusby, and S.D. Tachado. 1999. CD1d-
restricted immunoglobulin G formation to GPI-anchored an-
tigens mediated by NKT cells. Science. 283:225–229.
16. Chen, Y.H., N.M. Chiu, M. Mandal, N. Wang, and C.R.
Wang. 1997. Impaired NK11 T cell development and early
IL-4 production in CD1-deficient mice. Immunity. 6:459–467.
17. Mendiratta, S.K., W.D. Martin, S. Hong, A. Boesteanu, S.
Joyce, and L. Van Kaer. 1997. CD1d1 mutant mice are defi-
cient in natural T cells that promptly produce IL-4. Immu-
nity. 6:469–477.
18. Smiley, S.T., M.H. Kaplan, and M.J. Grusby. 1997. Immu-
noglobulin E production in the absence of interleukin-4
secreting CD1-dependent cells. Science. 275:977–979.
19. Bendelac, A., N. Killeen, D. Littman, and R.H. Schwartz.
1994. A subset of CD41 thymocytes selected by MHC class I
molecules. Science. 263:1774–1778.
20. Hammond, K., W. Cain, I. Driel, and D. Godfrey. 1998.
Three day neonatal thymectomy selectively depletes NK1.11
T cells. Int. Immunol. 10:1491–1499.
21. Kikly, K., and G. Dennert. 1992. Evidence for extrathymic
development of TNK cells. NK11 CD31 cells responsible for
acute marrow rejection are present in thymus-deficient mice.
J. Immunol. 149:403–412.
22. Sato, K., K. Ohtsuka, K. Hasegawa, S. Yamagiwa, H.
Watanabe, H. Asakura, and T. Abo. 1995. Evidence for ex-
trathymic generation of intermediate T cell receptor cells in
the liver revealed in thymectomized, irradiated mice sub-
jected to bone marrow transplantation. J. Exp. Med. 182:
759–767.
23. Arase, H., S. Ono, N. Arase, S.Y. Park, K. Wakizaka, H.
Watanabe, H. Ohno, and T. Saito. 1995. Developmental ar-
rest of NK1.11 T cell antigen receptor (TCR)-a/b1 T cells
and expansion of NK1.11 TCR-g/d1 T cell development in
CD3z-deficient mice. J. Exp. Med. 182:891–895.
24. Di Santo, J.P., and H. Rodewald. 1998. In vivo roles of re-
ceptor tyrosine kinases and cytokine receptors in early thy-
mocyte development. Curr. Opin. Immunol. 10:196–207.
25. Ohteki, T., S. Ho, H. Suzuki, T.W. Mak, and P.S. Ohashi.
1997. Role for IL-15/IL-15 receptor b-chain in natural killer
1.11 T cell receptor-ab1 cell development. J. Immunol. 159:
5931–5935.
26. Alberola-Ila, J., K.A. Hogquist, K.A. Swan, M.J. Bevan, and
R.M. Perlmutter. 1996. Positive and negative selection in-
voke distinct signaling pathways. J. Exp. Med. 184:9–18.1195 Gadue et al. Brief Definitive Report
27. Watanabe, H., K. Ohtsuka, M. Kimura, Y. Ikarashi, K.
Ohmori, A. Kusumi, T. Ohteki, S. Seki, and T. Abo. 1992.
Details of an isolation method for hepatic lymphocytes in
mice. J. Immunol. Methods. 146:145–154.
28. Chomarat, P., and J. Banchereau. 1998. Interleukin-4 and in-
terleukin-13: their similarities and discrepancies. Int. Rev. Im-
munol. 17:1–52.
29. Coles, M.C., and D.H. Raulet. 1994. Class I dependence of
the development of CD41 CD82 NK1.11 thymocytes. J.
Exp. Med. 180:395–399.
30. Chiu, Y., J. Jayawardena, A. Weiss, D. Lee, S. Park, A.
Dautry-Varsat, and A. Bendelac. 1999. Distinct subsets of
CD1d-restricted T cells recognize self-antigens loaded in dif-
ferent cellular compartments. J. Exp. Med. 189:103–110.
31. Olszowy, M.W., P.L. Leuchtmann, A. Veillette, and A.S.
Shaw. 1995. Comparison of p56lck and p59fyn protein expres-
sion in thymocyte subsets, peripheral T cells, NK cells, and
lymphoid cell lines. J. Immunol. 155:4236–4240.
32. Lantz, O., L.I. Sharara, F. Tilloy, A. Andersson, and J.P. Di
Santo. 1997. Lineage relationships and differentiation of NK
T cells: intrathymic selection and IL-4 production in the ab-
sence of NKR-P1 and Ly49 molecules. J. Exp. Med. 185:
1395–1401.
33. Anderson, S.J., K.M. Abraham, T. Nakayama, A. Singer, and
R.M. Perlmutter. 1992. Inhibition of T-cell receptor b-chain
gene rearrangement by overexpression of the non-receptor
protein tyrosine kinase p56lck. EMBO (Eur. Mol. Biol. Or-
gan.) J. 11:4877–4886.
34. Mombaerts, P., S.J. Anderson, R.M. Perlmutter, T.W. Mak,
and S. Tonegawa. 1994. An activated lck transgene promotes
thymocyte development in RAG-1 mutant mice. Immunity.
1:261–267.
35. Utting, O., S.J. Teh, and H.S. Teh. 1998. T cells expressing
receptors of different affinity for antigen ligands reveal a
unique role for p59fyn in T cell development and optimal
stimulation of T cells by antigen. J. Immunol. 160:5410–5419.